Previous 10 | Next 10 |
2024-03-21 11:27:34 ET Summary Revvity, Inc. is a major laboratory instrument and service provider to the healthcare industry. The company has historically underperformed compared to its peers in terms of profit generation and growth. Revvity has implemented a business restruc...
2024-03-20 04:33:40 ET Summary Cytek Biosciences is a leading cellular analysis instrument maker with a focus on the Aurora flow cytometry platform. Despite a downturn in the healthcare market, Cytek has maintained revenue growth above 15% since IPO. Cytek's technological adva...
2024-03-18 06:46:25 ET Summary I have been actively reshaping my portfolio by selling off low-conviction holdings and focusing on high-growth compounders. I have reduced my holdings from roughly 90 to roughly 70 over the past 6 months or so. I am excited about my current alloc...
2024-03-13 11:35:45 ET Summary The Lazard Global Total Return and Income Fund Inc offers a high level of current income without sacrificing potential equity gains. The LGI closed-end fund has outperformed major indices recently, despite having lower exposure to mega-cap technology...
2024-03-09 12:28:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-09 08:35:48 ET Summary GE HealthCare Technologies is expected to see profits and cash flows rise in 2024, leading to a potential strong upside for the stock. The company's revenue growth was driven by higher prices and increased volume, with the Pharmaceutical Diagnostics ...
2024-03-05 22:43:45 ET Summary Dan Loeb's 13F portfolio value increased to $6.64B this quarter, with the top three holdings accounting for ~37% of the portfolio. Third Point returned 3.4% in 2023 compared to 26.3% for the S&P 500 Index. New stakes include Fleetcor Tech, Ve...
2024-03-05 15:15:02 ET Danaher Corporation (DHR) TD Cowen 44th Annual Health Care Conference March 05, 2024 11:10 AM ET Company Participants Rainer Blair - President, CEO Conference Call Participants Dan Brennan - TD Cowen Presentation Dan Brenn...
2024-03-05 14:55:11 ET More on S&P 500 Index: The Magnificent 7 Are Falling Like Dominos; Only 3 Remain ETF Arbitrage: A Timely Strategy For S&P 500 Lovers Is There A Bubble In The Stock Market? Nasdaq slips more than 1% as Tesla, Apple lead tech loss...
Danaher to Present at TD Cowen Health Care Conference PR Newswire WASHINGTON , Feb. 27, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair , will be presenting at the TD Cowen Healthcare ...
News, Short Squeeze, Breakout and More Instantly...
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
Beckman Coulter's DxI 9000 Immunoassay Analyzer Honored at Premier, Inc.'s Annual Supplier Innovation Celebration PR Newswire BREA, Calif. , July 25, 2024 /PRNewswire/ -- Beckman Coulter Diagnostics, a clinical diagnostics leader, today announced that the Dx...
2024-07-23 20:30:03 ET Goldman Sachs analyst issues NEUTRAL recommendation for DHR on July 23, 2024 06:19PM ET. The previous analyst recommendation was Neutral. DHR was trading at $264.18 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cu...